In people with type 2 diabetes, the body either does not produce enough insulin or does not use it effectively
Yet, these are the very populations now being considered for treatment
Results from human studies show that urinary concentration of higenamine in participants exceeded 10ng/mL, leading to an Adverse Analytical Finding
What, then would the response rate be
Clinical efficacy depends on dose, injection frequency, and your individual metabolic responsenot on whether your medication came from a major pharmaceutical manufacturer or a licensed 503A compounding pharmacy
However, GLP-1 can act as a helpful addition especially for patients who: Have obesity or are overweight Have type 2 diabetes or metabolic syndrome Need improvements in multiple metabolic risk factors (not just cholesterol) Who Benefits Most The cholesterol and lipid benefits of GLP-1 tend to be greater in: People who lose significant weight on it Those with elevated triglycerides to start Patients with insulin resistance or type 2 diabetes Individuals implementing lifestyle changes (diet, physical activity, etc.) alongside medication What to Expect & Important Things to Know Timeframe : Changes in lipid levels usually show up over months not immediately